In order to validate, or perhaps disprove, the belief that consuming grapefruit is a sensible weight loss strategy, researchers at Vanderbilt University Medical Center have launched a two-year, three-arm randomized controlled study to see just how consumption of grapefruit and grapefruit juice affects appetite, dietary intake, weight loss and body composition.
Nancy Andreasen, M.D., Ph.D., a professor of Psychiatry at the University of Iowa, has been selected as the first recipient of the “Vanderbilt Prize in Biomedical Science.”
Tennessee’s Legislature is again seriously considering a repeal of the state’s mandatory motorcycle helmet law for adults.
Vanderbilt Medical Center laboratories will be joining the many laboratories across the country that observe and celebrate National Medical Laboratory Professionals Week (NMLPW).
Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant
Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.